Congress SMid Growth ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Congress SMID Growth ETF CSMD
Morningstar’s Analysis CSMD
Will CSMD outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 31.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Rubrik Inc Class A Shares | 4.10 | 19M | Technology |
Halozyme Therapeutics Inc | 3.68 | 17M | Healthcare |
Repligen Corp | 3.46 | 16M | Healthcare |
Valmont Industries Inc | 3.34 | 16M | Industrials |
Rambus Inc | 3.17 | 15M | Technology |
UFP Technologies Inc | 3.01 | 14M | Healthcare |
Medpace Holdings Inc | 2.85 | 13M | Healthcare |
Ligand Pharmaceuticals Inc | 2.74 | 13M | Healthcare |
nVent Electric PLC | 2.74 | 13M | Industrials |
Samsara Inc Ordinary Shares - Class A | 2.72 | 13M | Technology |